Pressmeddelanden från Genetic Analysis

Genetic Analysis AS and Pangea Laboratory LLC announces the launch of GA-map® MHI GutHealth in the USA

OSLO, NORWAY/IRVINE, CA, USA – 29 July 2025: Microbiome DX company Genetic Analysis AS (“GA”) and Pangea Laboratory LLC (“Pangea”) announces...

Cision • 29 Jul 08:30

Genetic Analysis subsequent offering to existing shareholders has now been registered with the Norwegian Register of Business Enterprises

Genetic Analysis AS' (“GA” or the “Company”) subsequent offering to existing shareholders, for which the subscription period ended on June 1...

Cision • 27 Jun 15:10

Genetic Analysis announces final outcome of the subsequent offering to existing shareholders

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 18 Jun 10:40

Genetic Analysis: Direct issue has now been registered with the Norwegian Register of Business Enterprises

OSLO, NORWAY - June 18, 2025: Microbiome DX company Genetic Analysis AS ("GA" or the "Company") hereby announces that the direct issue which...

Cision • 18 Jun 09:30

Genetic Analysis announces preliminary outcome of the subsequent offering to existing shareholders

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 16 Jun 16:30

Genetic Analysis AS: Mandatory notification of trade

OSLO, NORWAY – 12 June 2025: Genetic Analysis AS (“GA” or “the Company”) announces that members of the Board and Management have subscribed ...

Cision • 12 Jun 13:10

Today is the last day for trading in the subscription rights for subscribing for shares in Genetic Analysis

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 12 Jun 08:00

Today the subscription period in Genetic Analysis subsequent offering begins

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 05 Jun 08:00

Genetic Analysis first day of trading excluding subscription rights

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 03 Jun 08:00

Genetic Analysis publishes Simplified disclosure document relating to the previously announced subsequent offering

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 02 Jun 14:15

Genetic Analysis Last day of trading including subscription rights

Oslo, Norway, June 2, 2025 - Genetic Analysis AS ("GA" or the "Company") hereby announces that today, the 2[nd] of June, 2025, is the last d...

Cision • 02 Jun 08:00

Correction: Publication of Q1 report January – March 2025

Correction due to an incorrect EBITDA figure. In the previously published report, EBITDA was incorrectly stated as NOK -3.

Cision • 27 May 15:40

Genetic Analysis announces details of Subsequent Offering following directed issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 27 May 08:56

Publication of Q1 report January – March 2025

OSLO, NORWAY – May 27 2025: Genetic Analysis AS ("GA" or the "Company") hereby publishes the interim report for the period January 1 - March...

Cision • 27 May 08:00

Genetic Analysis AS: Mandatory notification of trade

OSLO, NORWAY – 20 May 2025: Genetic Analysis AS (“GA” or “the Company”) announces that members of the Board and Management have been allocat...

Cision • 20 May 09:05

Minutes from the Annual General Meeting 2024 in Genetic Analysis AS

OSLO, NORWAY – 20 May 2025: Genetic Analysis AS (the "Company", Ticker: GEAN) held its Annual General Meeting yesterday, May 19th, at 15:00 ...

Cision • 20 May 09:03

Correction: Genetic Analysis announces placement of a directed share issue of NOK 12.8 million

Correction due to an incorrect date in the preamble regarding the calculation of the subscription price.

Cision • 05 May 09:45

Notice of annual general meeting

OSLO, NORWAY – 5 May 2025: Notice is hereby served that the annual general meeting in Genetic Analysis AS (the "Company") will be held on Mo...

Cision • 05 May 08:05

Genetic Analysis announces proposed changes to the Board

OSLO, NORWAY – 5 May 2025: Genetic Analysis AS (the "Company", Ticker: GEAN) today announces that its Election Committee has proposed the ap...

Cision • 05 May 08:02

Genetic Analysis announces placement of a directed share issue of NOK 12.8 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 05 May 08:00

Genetic Analysis AS publishes Annual Report 2024

OSLO, NORWAY – 2 May 2025: Genetic Analysis AS (the "Company", Ticker: GEAN) hereby publishes the Annual Report for the financial year of 20...

Cision • 02 May 09:00

Genetic Analysis AS and Thalys Medical Technology Group are pleased to announce the launch of a microbiome test to the Chinese Consumer Health market

OSLO, NORWAY/SHANGHAI, CHINA – 22. April 2025: Microbiome DX company Genetic Analysis AS (“GA”) and Thalys Medical Technology Group Corporat...

Cision • 22 Apr 08:00

Genetic Analysis AS publishes year-end report 2024

OSLO, NORWAY – 26 February 2025: Genetic Analysis AS (the "Company", Ticker: GEAN) hereby publishes the year-end report for the period 1 Jan...

Cision • 26 Feb 08:00

GENETIC ANALYSIS AND FERRING PHARMACEUTICALS ANNOUNCE A COLLABORATION TO DEVELOP A NEW MICROBIOME RAPID DIAGNOSTIC TEST

· Collaboration announced to develop and launch a new rapid microbiome-based PCR test, aiming to provide increased standardisation in a q...

Cision • 20 Dec 2024 17:12

Genetic Analysis AS: Mandatory notification of trade – Primary Insiders

OSLO, NORWAY – 25 November 2024: Genetic Analysis AS (“GA” or “the Company”) announces that members of the management has bought GEAN-shares...

Cision • 25 Nov 2024 08:00

Genetic Analysis AS: Interim report January – September 2024

OSLO, NORWAY – 15 November 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for t...

Cision • 15 Nov 2024 08:00

Genetic Analysis AS: Publication of Half-year report 2024

OSLO, NORWAY – 30 August 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for H1,...

Cision • 30 Aug 2024 08:00

Genetic Analysis directed issue to major shareholders has now been registered with the Norwegian Register of Business Enterprises

Genetic Analysis AS' (“GA” or the “Company”) directed issue to current major shareholders and certain members of the board of directors and ...

Cision • 14 Aug 2024 08:00

Genetic Analysis AS: Minutes from the Extraordinary General Meeting 17 July 2024

Oslo, Norway, July 17, 2024 - Genetic Analysis AS (the "Company", Ticker: GEAN) held an Extraordinary General Meeting today, July 17[th], at...

Cision • 17 Jul 2024 17:30

Genetic Analysis: Direct issue has now been registered with the Norwegian Register of Business Enterprises

OSLO, NORWAY - July 15, 2024: Microbiome DX company Genetic Analysis AS ("GA" or the "Company") hereby announces that the direct issue which...

Cision • 15 Jul 2024 08:00

Genetic Analysis AS: Mandatory notification of trade – Primary Insider

OSLO, NORWAY – 04 July 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management has bought GEAN-shares.

Cision • 04 Jul 2024 08:00

Genetic Analysis AS: Notice of Extraordinary General Meeting 2024

Oslo, Norway, July 3, 2024 - Notice is hereby served that an extraordinary general meeting of Genetic Analysis AS (the "Company") will be he...

Cision • 03 Jul 2024 15:00

Genetic Analysis: Flagging notification

OSLO, NORWAY - July 1, 2024: Microbiome DX company Genetic Analysis AS ("GA" or the "Company") hereby announces that an existing shareholder...

Cision • 01 Jul 2024 10:43

Genetic Analysis announces placement of a directed share issue of approximately NOK 4.97 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 01 Jul 2024 09:00

Genetic Analysis: Awarded important EU patent covering a companion diagnostic method for optimising IBS interventions

OSLO, NORWAY – 13 June 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces today the grant of an important pat...

Cision • 13 Jun 2024 08:00

Genetic Analysis AS: CFO resigns to pursue other opportunities

OSLO, NORWAY – 06 June 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that Eilert Aamodt has decided to r...

Cision • 06 Jun 2024 08:00

Genetic Analysis AS: Mandatory notification of trade – Primary Insider

OSLO, NORWAY – 3 June 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the board of directors has bought GEAN-sh...

Cision • 03 Jun 2024 08:00

Genetic Analysis AS: Mandatory notification of trade – Primary Insider

OSLO, NORWAY – 31 May 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the board of directors has bought GEAN-sh...

Cision • 31 May 2024 08:00

Genetic Analysis AS: Publication of Q1 report January – March 2024

OSLO, NORWAY – May 29, 2024: Today, Microbiome DX company Genetic Analysis AS ("GA" or the "Company") hereby publishes the interim report fo...

Cision • 29 May 2024 08:00

Minutes from the Annual General Meeting 2024 in Genetic Analysis AS

Oslo, Norway, May 15, 2024 - Genetic Analysis AS (the "Company", Ticker: GEAN) held its Annual General Meeting yesterday, May 14[th], at 15:...

Cision • 15 May 2024 08:00

Genetic Analysis AS: Notice of Annual General Meeting 2024

Oslo, Norway, April 24, 2024 - Notice is hereby served that the annual general meeting of Genetic Analysis AS (the "Company") will be held o...

Cision • 24 Apr 2024 18:30

Genetic Analysis AS: Mandatory notification of trade – Primary Insider

OSLO, NORWAY – 19 April 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management has bought GEAN-shares.

Cision • 19 Apr 2024 08:00

Genetic Analysis AS: Publication of Annual Report 2023

Oslo, Norway, April 18, 2024 - Genetic Analysis AS (the "Company", Ticker: GEAN) hereby publishes the Annual Report for the financial year o...

Cision • 18 Apr 2024 08:00

Genetic Analysis AS: Mandatory notification of trade – Primary Insider

OSLO, NORWAY – 14 March 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management has bought GEAN-shares.

Cision • 14 Mar 2024 08:00

Genetic Analysis AS: Mandatory notification of trade – Primary Insider

OSLO, NORWAY – 11 March 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management has bought GEAN-shares.

Cision • 11 Mar 2024 08:00

Bokslutskommuniké januari – december 2023

Oslo, Norge, 29 februari 2024 - Genetic Analysis AS ("Bolaget", Ticker: GEAN) offentliggör härmed bokslutskommuniké avseende 2023.

Cision • 29 Feb 2024 08:00

Year-end report January – December 2023

Oslo, Norway, February 29, 2024 - Genetic Analysis AS (the "Company", Ticker: GEAN) hereby publishes the year-end report for the period 1 Ja...

Cision • 29 Feb 2024 08:00

Genetic Analysis AS: Genetic Analysis AS announces CE-IVDR marking for its GA-map® Sample Collection Kit

Oslo, Norway, November 26, 2024 - Genetic Analysis AS (the "Company", Ticker: GEAN) is proud to announce that its GA-map® Sample Collection ...

Cision • 26 Feb 2024 08:00

Genetic Analysis AS: Genetic Analysis AS erhåller CE-IVDR-märkning för sitt GA-map® provtagningskit

Oslo, Norge, 26 februari, 2024 - Genetic Analysis AS ("Bolaget", Ticker: GEAN) är stolta över att meddela att GA-map® Sample Collection Kit ...

Cision • 26 Feb 2024 08:00

Genetic Analysis subsequent offering to existing shareholders has now been registered with the Norwegian Register of Business Enterprises

Genetic Analysis AS' (“GA” or the “Company”) subsequent offering to existing shareholders, for which the subscription period ended on Decemb...

Cision • 10 Jan 2024 14:01

Genetic Analysis announces final outcome of the subsequent offering to existing shareholders

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 27 Dec 2023 13:00

Genetic Analysis announces preliminary outcome of the subsequent offering to existing shareholders

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 22 Dec 2023 14:45

Genetic Analysis ingår partnerskap för att ta steget in på konsumentmarknaden med GA-map®

OSLO, NORGE – 21 december 2023: Mikrobiom DX-bolaget Genetic Analysis AS ("GA" eller "Bolaget") tillkännager idag ett samarbete med Comono A...

Cision • 21 Dec 2023 08:00

Genetic Analysis partners up to enter the consumer market with GA-map®

OSLO, NORWAY - December 21, 2023: Today, Microbiome DX company Genetic Analysis AS ("GA" or the "Company") announces a collaboration with Co...

Cision • 21 Dec 2023 08:00

BioStock: Genetic Analysis mot fortsatt expansion

Norge-baserade Genetic Analysis har utvecklat världens enda, enligt bolaget, CE-IVD-märkta rutindiagnostiska verktyg för analys av tarmmikro...

Cision • 15 Dec 2023 08:33

Genetic Analysis sammanfattar årets produktutvecklingsaktiviteter och blickar framåt mot 2024

OSLO, NORGE - 13 december 2023: Idag publicerar mikrobiom DX-bolaget Genetic Analysis AS ("GA" eller "Bolaget") en sammanfattning av innevar...

Cision • 13 Dec 2023 08:00

Genetic Analysis summarizes this year's product development activities and looks ahead to 2024

OSLO, NORWAY - December 13, 2023: Today, the Microbiome DX company Genetic Analysis AS ("GA" or the "Company") publishes a summary of the cu...

Cision • 13 Dec 2023 08:00

BioStock: Genetic Analysis vd: ”vi är unikt positionerade för tillväxt”

Norska Genetic Analysis har utvecklat, enligt bolaget, världens enda CE-IVD-märkta rutindiagnostiska verktyg för analys av tarmens mikrobiot...

Cision • 12 Dec 2023 08:53

Today, the subscription period in Genetic Analysis subsequent offering begins

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 11 Dec 2023 08:00

Genetic Analysis publishes information memorandum relating to the previously announced subsequent offering

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 08 Dec 2023 15:40

Genetic Analysis announces final number of subscription rights received per existing share in the previously announced subsequent offering

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 08 Dec 2023 13:35

Genetic Analysis announces terms of the previously announced subsequent offering to shareholders of up to appr. NOK 9 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 30 Nov 2023 18:00

Genetic Analysis AS offentliggör utfall i optionsinlösen

OSLO, NORGE - 23 november, 2023 – Den 22 november 2023 avslutades nyttjandeperioden för de teckningsoptioner av serie TO 2 som emitterades i...

Cision • 23 Nov 2023 18:00

Genetic Analysis AS: Mandatory notification of trade

OSLO, NORWAY – 20 November 2023: Genetic Analysis AS (“GA” or “the Company”) announces that members of the Board and Management have been al...

Cision • 20 Nov 2023 14:35

Genetic Analysis AS: Minutes from the Extraordinary General Meeting

Oslo, Norway, November 20, 2023 - Genetic Analysis AS (the "Company", Ticker: GEAN) held an Extraordinary General Meeting today, November 20...

Cision • 20 Nov 2023 14:30

Presentation av GA-map® från Genetic Analysis väcker stort intresse på xMAP® Connect EMEA i Amsterdam

OSLO, NORGE – 16 november 2023: Mikrobiom DX-företaget Genetic Analysis AS (“GA” eller “Bolaget”) meddelar idag att Bolaget nyligen presente...

Cision • 16 Nov 2023 15:08

Presentation of GA-map® by Genetic Analysis sparks great interest at xMAP® Connect EMEA in Amsterdam

OSLO, NORWAY, November 16, 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces today that the Company recently...

Cision • 16 Nov 2023 15:08

Genetic Analysis – Capital raise give boost – Mangold Insight Analysis

Genetic Analysis, a diagnostic company within Life Science, is growing rapidly.

Cision • 16 Nov 2023 08:00

Notice of Extraordinary General Meeting 2023

Notice is hereby served that an extraordinary general meeting in Genetic Analysis AS (the "Company") will be held on Monday 20 November 2023...

Cision • 06 Nov 2023 13:13

Information avseende nyttjandeperiod av teckningsoptioner av serie TO 2 i Genetic Analysis AS

OSLO, NORGE - 3 november, 2023 – Den 8 november 2023 inleds nyttjandeperioden för de teckningsoptioner av serie TO 2 som emitterades i samba...

Cision • 03 Nov 2023 18:00

Correction: Updated intended record date for the intended Subsequent Offering announced in press release, November 2, 2023

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 03 Nov 2023 16:16

Subscriptions received in separate tranche of previously announced directed share issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 03 Nov 2023 08:56

Styrelseledamot avgår på egen begäran

OSLO, NORGE – 2 november, 2023: Mikrobiom DX-bolaget Genetic Analysis AS ("GA") meddelar idag att styrelseledamoten Staffan Strömberg har av...

Cision • 02 Nov 2023 20:31

Board member resigns at his request

OSLO, NORWAY – November 2, 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces today that the board member Sta...

Cision • 02 Nov 2023 20:31

Delårsrapport januari–september 2023

OSLO, NORGE, 2 november 2023 – Genetic Analysis AS (“GA” eller “Bolaget”) offentliggör härmed delårsrapport avseende det tredje kvartalet oc...

Cision • 02 Nov 2023 20:10

Interim report January – September 2023

OSLO, NORWAY, November 2, 2023 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for the third quarter and t...

Cision • 02 Nov 2023 20:10

Genetic Analysis announces placement of directed share issue of appr. NOK 10 mill, intention to conduct subsequent offering to shareholders, non-binding LoI for further investment, updated milestones

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 02 Nov 2023 20:00

Genetic Analysis: Launch of GA-map® Discovery – A microbiome profiling offering for Research Customers

OSLO, NORWAY – 24 October 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces today that the Company launches ...

Cision • 24 Oct 2023 08:00

Genetic Analysis: Lansering av GA-map® Discovery – Ett mikrobiomprofileringserbjudande för forskningskunder

OSLO, NORGE – 24 oktober 2023: Mikrobiom DX-företaget Genetic Analysis AS (“GA” eller “Bolaget”) meddelar idag att Bolaget lanserar GA-map® ...

Cision • 24 Oct 2023 08:00

Genetic Analysis: Initierat utvecklingsprojekt för nytt companion diagnostic-test

OSLO, NORGE, 12 oktober 2023 – Genetic Analysis AS (“GA” eller “Bolaget”) meddelar att Bolaget framgångsrikt har slutfört ett pilotprojekt o...

Cision • 12 Oct 2023 08:00

Genetic Analysis: Development project initiated for a new companion diagnostic test

OSLO, NORWAY – 12 October 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that the Company has successfull...

Cision • 12 Oct 2023 08:00

Genetic Analysis - Growth and cost reduction – Mangold Insight Analys

Genetic Analysis, with its GA-map technology, increased sales by 22 percent in the second quarter to 3.

Cision • 06 Sep 2023 08:30

Genetic Analysis - Tillväxt och sänkta kostnader – Mangold Insight Analys

Genetic Analysis med dess GA-map teknologi ökade försäljningen med 22 procent under det andra kvartalet till 3,7 miljoner norska kronor* jäm...

Cision • 06 Sep 2023 08:30

Half-year report January–June 2023

OSLO, NORWAY, August 30, 2023 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the half-year report for the second quarter and...

Cision • 30 Aug 2023 08:00

Halvårsrapport januari–juni 2023

OSLO, NORGE, 30 augusti 2023 – Genetic Analysis AS (“GA” eller “Bolaget”) offentliggör härmed halvårsrapport avseende det andra kvartalet oc...

Cision • 30 Aug 2023 08:00

Genetic Analysis AS ramps up its market presence for the GA-map[®] microbiome testing in the US

OSLO, NORWAY – August 25, 2023: Microbiome diagnostics specialist, Genetic Analysis AS (“GA”) has through its distributor Eagle Biosciences ...

Cision • 25 Aug 2023 08:00

Genetic Analysis AS stärker sin marknadsnärvaro i USA med mikrobiomtestet GA-map[®]

OSLO, NORGE – 25 augusti 2023: Mikrobiomdiagnostikspecialisten Genetic Analysis AS ("GA") har genom sin distributör Eagle Biosciences Inc in...

Cision • 25 Aug 2023 08:00

Ny publikation visar fördelarna med testplattformen GA-map® vid diabetes typ 2

OSLO, NORGE - 23 augusti 2023: Mikrobiom DX-bolaget Genetic Analysis AS ("GA" eller "Bolaget") meddelar att en vetenskaplig artikel nyligen ...

Cision • 23 Aug 2023 08:00

New publication shows the benefits of the GA-map® testing platform in Diabetes Type 2

OSLO, NORWAY – 23 August 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that a scientific article has rec...

Cision • 23 Aug 2023 08:00

Genetic Analysis erhåller patentgodkännande i Sydafrika

OSLO, NORGE – 29 Juni 2023: Mikrobiom DX-bolaget Genetic Analysis AS ("GA" eller "Bolaget") meddelar att Bolaget har erhållit ett patentgodk...

Cision • 29 Jun 2023 08:00

Genetic Analysis receives patent approval in South Africa

OSLO, NORWAY – June 29, 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that the Company has been awarded ...

Cision • 29 Jun 2023 08:00

Genetic Analysis AS enters an agreement with ELTA90 Group to distribute and launch GA-map[®] technology in the Balkan region

OSLO, NORWAY – 8 June 2023: Molecular diagnostics specialist, Genetic Analysis AS (“GA”) has entered a distribution agreement with ELTA90 Gr...

Cision • 08 Jun 2023 08:00

Genetic Analysis AS ingår avtal med ELTA90 Group för att distribuera och lansera GA-map[®]-teknologin i Balkanregionen

Oslo, Norge, 8 Juni, 2023 – Genetic Analysis (”GA”), specialist på molekylär diagnostik, har ingått ett distributionsavtal med ELTA90 Group ...

Cision • 08 Jun 2023 08:00

Genetic Analysis - Diagnostik på tillväxt - Mangold Insight Analys

Genetic Analysis, ett medicintekniskt diagnostikbolag inriktat mot mikrobiom, ökade sina totala intäkter till 6,4 miljoner norska kronor* un...

Cision • 02 Jun 2023 13:00

Genetic Analysis - Diagnostic company on growth - Mangold Insight Analys

Genetic Analysis, a microbiome diagnostic company, increased its total revenue to NOK 6,4 million in the first quarter.

Cision • 02 Jun 2023 13:00

Genetic Analysis AS: Mandatory notification of trade – Primary Insiders

OSLO, NORWAY – 26 May 2023: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management has bought GEAN-shares.

Cision • 26 May 2023 08:00

Interim report January–March 2023

OSLO, NORWAY, May 25, 2023 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for the first quarter of 2023.

Cision • 25 May 2023 08:00

Delårsrapport januari–mars 2023

OSLO, NORGE, 25 maj 2023 – Genetic Analysis AS (“GA” eller “Bolaget”) offentliggör härmed delårsrapport avseende det första kvartalet 2023.

Cision • 25 May 2023 08:00

Minutes from the Annual General Meeting 2023 in Genetic Analysis AS

Oslo, Norway, May 11, 2023 - Genetic Analysis AS (the "Company", Ticker: GEAN) held its Annual General Meeting today, May 11[th], at 15:00 h...

Cision • 11 May 2023 16:49

Notice of Annual General Meeting 2023

Notice is hereby served that the annual general meeting of Genetic Analysis AS (the "Company") will be held on Thursday 11 May 2023 at 15:00...

Cision • 28 Apr 2023 08:00